Plasminogen Not Yet Recruiting Phase 2 Trials for Stroke, Acute, Stroke Ischemic Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04028518A Phaseâ…¡ of Injection for Recombinant Human Tissue Plasminogen Kinase Derivative in Treatment of Acute Ischemic Stroke.